Intellia Therapeutics, Inc. SEC filings NTLA

Intellia Therapeutics, Inc. has 721 filings in SEC EDGAR's recent list, going back to Sep 3, 2015. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 8, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Form Description Filed Period
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
10-Q Quarterly report May 11, 2026 Mar 31, 2026
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
10-Q Quarterly report May 4, 2023 Mar 31, 2023
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
10-Q Quarterly report May 5, 2022 Mar 31, 2022
10-Q Quarterly report Nov 4, 2021 Sep 30, 2021
10-Q Quarterly report Aug 5, 2021 Jun 30, 2021
10-Q Quarterly report May 6, 2021 Mar 31, 2021
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
10-Q Quarterly report Aug 6, 2020 Jun 30, 2020
10-Q Quarterly report May 7, 2020 Mar 31, 2020
10-Q Quarterly report Oct 31, 2019 Sep 30, 2019
10-Q Quarterly report Aug 1, 2019 Jun 30, 2019
10-Q Quarterly report May 2, 2019 Mar 31, 2019
10-Q/A Amended quarterly report May 2, 2019 Sep 30, 2018
10-Q Quarterly report Oct 31, 2018 Sep 30, 2018
10-Q Quarterly report Aug 1, 2018 Jun 30, 2018
10-Q Quarterly report May 1, 2018 Mar 31, 2018
10-Q Quarterly report Oct 31, 2017 Sep 30, 2017
10-Q Quarterly report Aug 1, 2017 Jun 30, 2017
10-Q Quarterly report May 2, 2017 Mar 31, 2017
10-Q Quarterly report Nov 1, 2016 Sep 30, 2016
10-Q Quarterly report Aug 4, 2016 Jun 30, 2016
10-Q Quarterly report Jun 3, 2016 Mar 31, 2016

Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
In Vitro & In Vivo Diagnostic Substances (SIC 2835)
Listed as
NTLA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cambridge, MA
SEC filer status
Large accelerated filer
SEC CIK
1652130

Other In Vitro & In Vivo Diagnostic Substances companies

All 21 In Vitro & In Vivo Diagnostic Substances companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.